Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

New potentiality in intraoperative OCT: clinical experience with Leica EnFocus 1system

Search Title by author or title

Session Details

Session Title: Cataract Surgery Equipment/Instrumentation/Surgical Devices

Session Date/Time: Monday 09/10/2017 | 16:30-18:00

Paper Time: 17:49

Venue: Room 4.4

First Author: : T.Galecki POLAND

Co Author(s): :    J. Szaflik   M. Lazicka-Galecka   J. Szaflik              

Abstract Details

Purpose:

To present clinical experience with new intraoperative OCT - Leica EnFocus 1 system

Setting:

.Department of Ophthalmology, Medical University of Warsaw, Poland

Methods:

.Leica EnFocus 1 is an intrasurgical spectral OCT integrated with surgical microscope. Aforementioned design allows for easy use during surgical procedure. Leica EnFocus comes in two options: EnFocus Ultra HD and EnFocus Ultra Deep. EnFocus UltraHD includes fine axial resolution ≤ 4 μm coupled with high OCT scan density The EnFocus Ultra-HD unfortunately like in the other intrasurgical OCT available on market, it produces strong image distortion when iris and deeper structures are visualized. Leica EnFocus Ultra-Deep OCT delivers very deep imaging, up to11 mm depth in tissue, what is extraordinary among others OCT’s, with > 20 mm scan length.

Results:

The lecture will focus on authors own experience with intraoperative use of both Leica EnFocus UltraHD and Leica EnFocus Ultra-Deep. Examples of intraoperative imaging acquired during anterior segment surgeries will be shown, including penetrating keratoplasty, endothelial keratoplasty, implantation of add-on intraocular lens, canaloplasty, and implantation of XEN gel-stent.

Conclusions:

Leica EnFocus UltraHD and Leica EnFocus Ultra-Deep allow to effective intraoperative evaluation of surgical procedures. It is valuable complement for operation theater instruments.

Financial Disclosure:

NONE

Back to previous